Company intelligence / Profile preview

Adacyte Therapeutics

Sant Cugat del Vallès or Sant Just Desvern, Catalonia, Spainadacyte.com ↗

Ownership: Private
Development stage: Commercial

Overview

Adacyte Therapeutics develops and commercializes innovative medical devices for the treatment of complex diseases such as ulcerative colitis and Crohn’s disease. Their lead product appears to be an adsorptive apheresis column for immune modulation, with established use in Europe. The company emphasizes improving quality of life for patients with IBD through non-immunosuppressive therapeutic approaches. No clinical trial results or drug development programs are publicly listed.

Therapeutic areas: GastroenterologyImmunology
Modalities: Medical device (specifically apheresis/adsorptive therapy devices)
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

Adacolumn

Commercial

Indications: Inflammatory bowel disease, Autoimmune diseases

Partnerships

Norgine (commercialization partnership for Adacolumn in Switzerland)Japan Immunoresearch Laboratories Company Limited/JIMRO Co., Ltd. (“exclusive partner” per press release)

Beyond the preview

Go deeper on Adacyte Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adacyte Therapeutics.

Explore the full profile